CME Group has launched Nasdaq CME Crypto Index futures, expanding its regulated digital asset derivatives lineup with contracts tied to a basket of major cryptocurrencies, including Bitcoin, Ether, Solana, XRP, Cardano, Chainlink, and Lumens.
The contracts are financially settled at expiration to the Nasdaq CME Crypto Settlement Price Index, which tracks the performance of the largest and most actively traded cryptocurrencies. As of June 9, the index includes Bitcoin, Bitcoin Cash, Ether, SOL, XRP, ADA, LINK, and Lumens.
CME said the product is designed to give investors diversified crypto exposure while retaining the transparency, capital efficiency, and risk management structure of a regulated futures marketplace. The launch comes as institutional interest in crypto derivatives continues to grow, even as CME leadership raises concerns about newer high-leverage products such as perpetual futures.
CME Adds Broad Crypto Index Exposure
The Nasdaq CME Crypto Index futures provide a single contract linked to multiple digital assets rather than one cryptocurrency. The structure allows traders to hedge or gain exposure to a broader crypto basket without managing separate futures positions across Bitcoin, Ether, Solana, XRP, ADA, LINK, and XLM-related markets.
Giovanni Vicioso, CME Group’s global head of cryptocurrency products, said the launch marks a milestone in the expansion of CME’s regulated digital asset marketplace. He said investors are seeking diversified crypto exposure during volatile markets while maintaining access to regulated infrastructure.
Nasdaq’s Sean Wasserman said investor participation in digital assets is increasing, along with demand for benchmarks built with governance and transparency standards similar to those used in other asset classes. He said futures linked to such indexes can support market development.
The product builds on CME’s existing crypto derivatives business. CME has already listed standard and micro futures and options tied to Bitcoin and Ether, and it has continued expanding into new crypto-linked contracts as institutional demand increases.
Bitcoin Volatility Futures Expand Hedging Tools
The new index futures follow the launch of CME’s Bitcoin volatility index futures, which began trading last week. Those contracts track the CME CF Bitcoin Volatility Index, or BVX, which measures market expectations for Bitcoin volatility over the next four weeks.
DV Chain and Monarq Asset Management executed the first block trades in the volatility contracts. The product allows investors to trade expected Bitcoin price turbulence without taking a direct directional position on Bitcoin itself.
Traditional futures and options often require traders to take a view on price direction. Volatility futures allow market participants to position for how much Bitcoin may move, whether higher or lower, around events such as inflation data, central bank policy decisions or geopolitical developments.
Shiliang Tang, chief executive officer of Monarq, said regulated Bitcoin volatility futures provide another risk management tool as Bitcoin becomes a more institutional asset class.
CME’s crypto derivatives activity has continued to expand. The platform’s crypto derivatives business reached about 266,900 contracts year-to-date, up 38% from a year earlier. Average daily open interest stood near 274,500 contracts, up 18%.
CME CEO Warns on Crypto Perpetual Futures
The launch of new regulated products comes as CME Chief Executive Officer Terry Duffy has criticized the approval of perpetual crypto futures for U.S. markets. Speaking at a financial conference, Duffy warned that such products could create systemic risk because they often involve high leverage and no expiration date.
Perpetual futures allow traders to hold positions indefinitely without rolling contracts. Some products can offer leverage as high as 50-to-1, increasing both potential gains and losses.
Coinbase and Kalshi recently said they would launch perpetual crypto futures after receiving approval from the Commodity Futures Trading Commission. The approvals mark the first time such instruments are expected to become available to U.S. investors through domestic regulated exchanges.
Duffy said the combination of high leverage, funding costs, and automatic liquidation models could pose risks for retail investors who may not fully understand how the products behave. He also said most CME activity remains institutionally driven, with 85% to 90% of its business coming from institutional clients.
